Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Screening for asymptomatic neurosyphilis in HIV patients after treatment of early syphilis: an observational study.

Tomkins A, Ahmad S, Cousins DE, Thng CM, Vilar FJ, Higgins SP.

Sex Transm Infect. 2017 Feb 14. pii: sextrans-2016-052938. doi: 10.1136/sextrans-2016-052938. [Epub ahead of print]

PMID:
28196838
2.

Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance.

Sarri G, Westby M, Bermingham S, Hill-Cawthorne G, Thomas H; Guideline Development Group.

BMJ. 2013 Jun 26;346:f3893. doi: 10.1136/bmj.f3893. No abstract available.

PMID:
23804177
3.

Presumed entecavir-induced ocular toxicity.

Muqit MK, Stanga PE, Vilar FJ, Patton N.

Eye (Lond). 2011 Dec;25(12):1665-8. doi: 10.1038/eye.2011.259. Epub 2011 Oct 21. No abstract available.

4.

Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent.

Yuan J, Guo S, Hall D, Cammett AM, Jayadev S, Distel M, Storfer S, Huang Z, Mootsikapun P, Ruxrungtham K, Podzamczer D, Haas DW; Nevirapine Toxicogenomics Study Team.

AIDS. 2011 Jun 19;25(10):1271-80. doi: 10.1097/QAD.0b013e32834779df.

5.

Managing hepatitis B/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil/emtricitabine) experienced patients.

Ratcliffe L, Beadsworth MB, Pennell A, Phillips M, Vilar FJ.

AIDS. 2011 May 15;25(8):1051-6. doi: 10.1097/QAD.0b013e328345ef5e.

PMID:
21346511
6.

Adipogenic gene variants in patients with HIV-associated lipodystrophy.

Pushpakom SP, Owen A, Vilar FJ, Castro H, Dunn DT, Back DJ, Pirmohamed M.

Pharmacogenet Genomics. 2011 Feb;21(2):76-83. doi: 10.1097/FPC.0b013e328342a917.

PMID:
21178827
7.

Reduction in neutrophil count during hepatitis C treatment: drug toxicity or predictor of good response?

Alvarez-Uria G, Day JN, Nasir AJ, Russell SK, Vilar FJ.

Dig Dis Sci. 2010 Jul;55(7):2058-62. doi: 10.1007/s10620-009-0969-z. Epub 2009 Sep 16.

PMID:
19757045
8.

Inflammatory BCG adenitis associated with immune reconstitution following allogeneic haematopoietic stem cell transplant in infancy.

Searle E, Patel H, Vilar FJ, Gharib M, Turner AJ, Batra G, Wynn RF.

Pediatr Blood Cancer. 2010 Jan;54(1):166-9. doi: 10.1002/pbc.22143.

PMID:
19606456
9.

Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection.

Alvarez-Uria G, Day JN, Nasir AJ, Russell SK, Vilar FJ.

Liver Int. 2009 Aug;29(7):1051-5. doi: 10.1111/j.1478-3231.2008.01958.x.

PMID:
19580634
10.

Cardiovascular disease risk management in HIV patients, experiences from Greater Manchester.

Mallewa JE, Higgins SP, Garbett S, Saxena N, Vilar FJ.

Int J STD AIDS. 2009 Jun;20(6):425-6. doi: 10.1258/ijsa.2008.008295.

PMID:
19451331
11.

TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole.

Alfirevic A, Vilar FJ, Alsbou M, Jawaid A, Thomson W, Ollier WE, Bowman CE, Delrieu O, Park BK, Pirmohamed M.

Pharmacogenomics. 2009 Apr;10(4):531-40. doi: 10.2217/pgs.09.6.

PMID:
19374512
12.

Immune reconstitution associated with progressive multifocal leukoencephalopathy in human immunodeficiency virus: a case discussion and review of the literature.

Travis J, Varma A, duPlessis D, Turnbull I, Vilar FJ.

Neurologist. 2008 Sep;14(5):321-6. doi: 10.1097/NRL.0b013e31816e2f13. Review.

PMID:
18784604
13.

Audit of the management of antiretroviral treatment-naïve HIV patients in Greater Manchester, UK.

Ratcliffe L, McQuillan O, Higgins SP, Wilkins EG, Vilar FJ.

Int J STD AIDS. 2008 Jun;19(6):414-5. doi: 10.1258/ijsa.2007.007284.

PMID:
18595881
14.

Drug-specific T cells in an HIV-positive patient with nevirapine-induced hepatitis.

Drummond NS, Vilar FJ, Naisbitt DJ, Hanson A, Woods A, Park BK, Pirmohamed M.

Antivir Ther. 2006;11(3):393-5.

PMID:
16759058
15.

Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity.

Hughes DA, Vilar FJ, Ward CC, Alfirevic A, Park BK, Pirmohamed M.

Pharmacogenetics. 2004 Jun;14(6):335-42.

PMID:
15247625
16.

Mechanisms of drug hypersensitivity in HIV-infected patients: the role of the immune system.

Vilar FJ, Naisbitt DJ, Park BK, Pirmohamed M.

J HIV Ther. 2003 May;8(2):42-7. Review.

PMID:
12838164
17.

Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.

Farrell J, Naisbitt DJ, Drummond NS, Depta JP, Vilar FJ, Pirmohamed M, Park BK.

J Pharmacol Exp Ther. 2003 Jul;306(1):229-37. Epub 2003 Apr 3.

18.

Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity.

Alfirevic A, Stalford AC, Vilar FJ, Wilkins EG, Park BK, Pirmohamed M.

Br J Clin Pharmacol. 2003 Feb;55(2):158-65.

19.

TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy.

Maher B, Alfirevic A, Vilar FJ, Wilkins EG, Park BK, Pirmohamed M.

AIDS. 2002 Oct 18;16(15):2013-8.

PMID:
12370499
20.

Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection.

Naisbitt DJ, Vilar FJ, Stalford AC, Wilkins EG, Pirmohamed M, Park BK.

AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1929-38.

PMID:
11153075

Supplemental Content

Loading ...
Support Center